SUMMARY A new method of eliciting experimental pain in man is described. Microelectrodes are inserted percutaneously into the peripheral nerves of awake subjects, and are positioned close to nociceptive fibres in order to elicit pain during intraneural electrical stimulation. Under fixed stimulation conditions the estimated magnitude of evoked pain remains relatively stable, unless a high stimulus frequency is used, which may lead to excitation failure of nociceptive fibres. This method can be employed to test for possible central modulation of pain, for instance by analgesic agents, since peripheral receptors are bypassed.
The use of experimental pain in man in combination with psychophysics has made it possible to obtain quantitative data about the efficacy of analgesic agents. Most methods involve the application of radiant heat, algesic chemicals or electric currents to the skin, mucosae or accessible skeletal structures. Such tests, however, provide little information about the agent' s site of action, since they activate peripheral nociceptors and hence the whole nociceptive sensory system. In order to distinguish peripheral from central effects, it is necessary to employ a noxious stimulus which bypasses nociceptors but nevertheless selectively activates nociceptive units.
These conditions are fulfilled by the technique of intraneural electrical stimulation. Following the introduction of microneurography by Vallbo and Hagbarth,' it became possible to record afferent discharges directly from within the nerves of human subjects by means of tungsten microelectrodes. A further development was the use of the same intraneural electrodes to stimulate electrically mechanoreceptive or nociceptive units.2 When the latter are activated intraneurally, subjects report pain projected to a discrete area of skin (or deep structures if the electrode tip is situated within a muscle nerve fascicle) supplied by the impaled nerve. Such pain can be reproduced at will and is amenable to psychophysical magnitude estimation. If under these conditions an analgesic drug is administered or some other putatively painrelieving procedure is applied, any observed fluctuations in the estimated magnitude of pain cannot be due to depression of peripheral receptor sensitivity-regardless of whether this occurs or not-but rather to modification of central processing of nociceptive inputs. This technique therefore represents a new method of evoking experimental pain in man and provides a means of testing central effects of analgesic agents. In this report we describe the method and discuss factors which may affect its reproducibility.
Methods

Electrode insertion
Tungsten microelectrodes were inserted in the peripheral nerves of nine healthy subjects aged 22-44 years at either the median nerve in the upper arm, 10-15 cm above the elbow, the ulnar nerve at the wrist, the common peroneal nerve as it winds round the fibular head, or the superficial peroneal nerve in the lower leg. Electrodes were about 5 ,um wide at the tip and were coated with resin lacquer except for an exposed area at the tip less than 150 ,um long. They were inserted percutaneously into the nerve in accordance with standard microneurographic technique.'
A new method for demonstration of central effects of analgesic agents in man S48 constant voltage stimulator. This elicited muscle twitching and/or pain when a muscle nerve fascicle was impaled, and cutaneous sensations of various qualities when a skin nerve fascicle was impaled.4 5 By moving the electrode in small steps it was usually possible to place the tip in such a position that pain was evoked at low stimulus amplitudes, projected to either skin, muscle, joint or bone. A stimulation site was considered adequate if (a) pain was the first evoked sensation at a threshold no higher than 1 V, and (b) quality and threshold were consistent in repeated trials. At such sites C nociceptive or sympathetic activity could usually be discriminated when switching to recording mode. 6 One further preliminary experiment involved the use of two intraneural electrodes placed in the superficial peroneal nerve 4-5 cm apart, one to be used for stimulating, the other for recording purposes. Small adjustments were made in their position until they were both lying in the same fascicle, judging by the fact that the receptive fields of multi-unit responses recorded with them coincided, as did the projections of sensations evoked when stimulating intraneurally with either electrode. Electrical pulses were then delivered through the distal electrode while the proximal electrode was used for recording. In this way it was possible to monitor directly the responses of nociceptive fibres at different stimulus frequencies, and to correlate nociceptor activation with the magnitude of evoked pain.
Determination of variability in pain ratings over time In ten experiments the electrode was positioned in the same way as above and the stimulus amplitude was equally kept constant. Stimulus trains of 3 s duration at 10 Hz were repeatedly delivered at intervals of 5 or 10 min. On each occasion, the subject was asked to estimate the magnitude of evoked pain at its peak in numerical terms. The first stimulus train was presented as standard and assigned a value (usually 100). All subsequent magnitude estimations were done relative to this standard on an open-ended ratio scale. When a figure other than 100 was used as standard, values were later normalised and changes in pain ratings were expressed as a percentage of the initial standard value. In between trains, the stimulating electrode was occasionally used for recording in order to make sure there was no change in recordable afferent or efferent fibre activity. If there was, this was taken to indicate electrode shift and the experiment was terminated.
Test experiment using zomepirac The method was tested in a single experiment using the same procedure following oral administration of zomepirac sodium, a prostaglandin synthetase inhibitor with powerful analgesic properties. After establishing that recording conditions were stable and pain ratings remained unchanged for 30 min, a single oral dose of 100 mg was given. The effect on pain ratings was then studied for 150 min.
Results
QUALITY AND PROJECTION OF PAIN
Pain evoked by intraneural stimulation was described by most subjects as dull, aching or boring. Despite its vague aching character, it was fairly focally projected to a discrete circular or oval area of skin, muscle, joint or bone. The mean size of this area was 150 mm2 when projected to the skin and 500 mm2 when projected to deep structures, corresponding to diameters of 1-4 and 2-5 cm, respectively. Evoked pain was "pure" in five out of 11 experiments at the stimulus amplitudes required to produce at least moderately severe pain. Mean stimulus amplitudes used were 0 9 V when stimulating in the median nerve and 1 0 V when stimulating in the common peroneal nerve. At such amplitudes, pain was accompanied by a slight intermittent tap- The electrode tip was situated inside the common peroneal nerve, and evoked pain was projected to the ankle joint. During the first stimulus train, delivered at 10 Hz, the subject was instructed to bring the response lever to within the top third ofthe visual analogue scale when pain was maximal. The magnitude ofpain during subsequent stimulus trains at 5, 3 and I Hz was rated relatve to the maximum felt at 10 Hz. In 10 experiments, sequential pain ratings were studied for periods of up to two and a half hours (mean 101 min). The duration of an experiment was determined by the length of time it was possible to maintain a stable recording. Stimulus trains were delivered every 5 or 10 min. In one experiment, 10 min intervals were used during the first 100 min and 5 min intervals thereafter. Evoked pain was projected to the skin in three instances and to muscle, bone or joint in seven.
Sequential pain ratings remained relatively stable as long as there was no electrode shift. There was, however, a tendency for ratings to rise in the first 120r half hour and then to drop from the standard 100 to around 90 by one and a half hours (fig 3) . This drop was statistically significant when comparing mean rating at 30 min with that at 80 min (p < 0-05) but for no other two values. The gradual decline in ratings continued beyond 90 min to reach a value of 75 at 150 min in the one experiment where a stable recording could be maintained for this length of time. The initial rise in ratings was obvious only when evoked pain was "contaminated" by mild twitching or cutaneous tactile sensations (fig 4A) , and when 10 min intervals between stimulus trains were used ( fig 4B) . The subsequent decline in ratings appeared more pronounced with 5 min than with 10 min intervals between trains. Although this difference, like the one between the mean rating curves of "pure" vs. "contaminated" pain, was not statistically significant, the fall-off of ratings with 5 min intervals was sufficiently steep and consistent to suggest that, given larger numbers, it might have become so. In this context, the results of one experiment where both types of intervals were used are of interest. Stimulus trains repeated every 10 min evoked pain whose magnitude was rated at 85-100% of the standard for 100 min. At this point, the intervals between trains were shortened to 5 min, with the result that pain ratings dropped to 
before and 20 min after the administration of zomepirac. Ratings then decreased progressively to reach a minimum of 40% of the standard at around 90 min. Towards the end of the experiment pain ratings increased again. Throughout the experiment, the amplitude and latency of the recordable C unti potential remained unchanged.
Discussion
The method described involves excitation of nociceptive units-A delta or C nociceptive fibres, or group IIVI/V muscle afferents-directly in the nerves of human subjects without activation of peripheral receptors. That this is possible has been shown in previous reports: nociceptive units can be both selectively recorded from6-s and selectively activated intraneurally.29 10 In the present work it is likely that unmyelinated fibres were predominantly activated, rather than A delta nociceptive units, which, when projected to skin, mediate very focal pricking or stinging pain.2 9 1' By contrast, our subjects usually reported dull pain projected to an area over 1 cm across, consistent with activation of unmyelinated C fibres." It is furthermore likely that several unmyelinated axons were activated at the stimulus amplitudes used. A single or a few repeated impulses in a single afferent C unit are not perceived.9 12 Spatial and temporal summation are required to reach threshold for conscious detection, and much more so in order to reach the suprathreshold pain levels used in our experiments. Figure 1 provides clear evidence of the effect of temporal summation. At a constant stimulation intensity, the time required to reach a certain magnitude of pain is dependent on the stimulus frequency, that is, the number of impulses.
The reason why suprathreshold levels of stimulation were used, when threshold stimulus intensities would have induced pain uncontaminated by either muscle twitching or tactile cutaneous sensations is that, at threshold, evoked pain would have been too weak to allow accurate rating of small increments in magnitude over time. At least moderate pain was required for subjects to detect changes with confidence, both in our study and in previous clinical trials of analgesic drugs. ' 19 20 No significant differences in pain ratings over an equivalent time were observed in our study when stimulating at 5 min and at 10 min intervals, but there was a trend for ratings to drop with time when using 5 min intervals suggesting pain suppression at central levels. For this reason we would recommend the use of 10 min intervals in future studies on central activity of analgesic agents.
Two conditions must be satisfied for the method to be used meaningfully: (a) the electrode must be placed in such a position that intraneural stimulation causes exclusively or predominantly pain, and (b) the electrode tip must remain in a stable position in the nerve, as judged by unchanging recordable activity, so that the number of nociceptive fibres excited by identical electrical shocks does not alter. The first requirement is not absolute, since the technique has been employed to study the pain-relieving effects of vibration and cooling when coactivating nociceptors and mechanoreceptors.2' However, activation of non-nociceptive units in large numbers introduces unknown factors which may affect the reproducibility of the method. Under carefully controlled conditions, the method may thus be a reliable, if technically difficult, way of studying the central effects of pain-relieving procedures and, in particular, of analgesic drugs. The result of the pilot study with zomepirac indicates that the method is applicable in practice. The drop in and subsequent recovery of pain ratings following a single dose of the drug, in the setting of an extremely stable electrode position, suggest that zomepirac does have central analgesic effects in addition to inhibiting prostaglandin synthesis in the periphery. This has already been postulated on the basis of neurophysiological and immunological tests in experimental animals.2223 However, confirmation of this finding in man awaits a controlled study using a method such as the one described.
